{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:57:51Z","timestamp":1781326671077,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.amjoto.2025.104765","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:49:46Z","timestamp":1764661786000},"page":"104765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stapokibart (CM310): A review in seasonal allergic rhinitis"],"prefix":"10.1016","volume":"47","author":[{"given":"Ping","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjoto.2025.104765_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis - 2023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"issue":"8","key":"10.1016\/j.amjoto.2025.104765_bb0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/all.12874","article-title":"An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011","volume":"71","author":"Wang","year":"2016","journal-title":"Allergy"},{"issue":"Suppl. 86","key":"10.1016\/j.amjoto.2025.104765_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.amjoto.2025.104765_bb0020","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jaci.2021.10.011","article-title":"Climate change and global issues in allergy and immunology","volume":"148","author":"Pacheco","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.amjoto.2025.104765_bb0025","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/all.14476","article-title":"The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens","volume":"75","author":"D\u2019Amato","year":"2020","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.amjoto.2025.104765_bb0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/all.13099","article-title":"Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN study","volume":"72","author":"Col\u00e1s","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.amjoto.2025.104765_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2017.09.002","article-title":"Impact of rhinitis on work productivity: a systematic review","volume":"6","author":"Vandenplas","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.amjoto.2025.104765_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1398-9995.2000.00526.x","article-title":"Consensus statement on the treatment of allergic rhinitis. European academy of Allergology and clinical immunology","volume":"55","author":"van Cauwenberge","year":"2000","journal-title":"Allergy"},{"issue":"1 Suppl","key":"10.1016\/j.amjoto.2025.104765_bb0045","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mai.2001.115569","article-title":"Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis","volume":"108","author":"Skoner","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.amjoto.2025.104765_bb0050","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/cea.12638","article-title":"Pollinosis and all-cause mortality among middle-aged and elderly Japanese: a population-based cohort study","volume":"46","author":"Konishi","year":"2016","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.amjoto.2025.104765_bb0055","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1398-9995.2005.00602.x","article-title":"Seasonal and perennial allergic rhinitis: is this classification adherent to real life?","volume":"60","author":"Ciprandi","year":"2005","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.amjoto.2025.104765_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13223-015-0093-x","article-title":"Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis","volume":"11","author":"K\u00f6nig","year":"2015","journal-title":"Allergy, Asthma Clin Immunol"},{"issue":"6","key":"10.1016\/j.amjoto.2025.104765_bb0065","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/alr.23098","article-title":"Rhinitis symptom in patients with self-reported allergic rhinitis is influenced by sensitization pattern: a cross-sectional study of China","volume":"13","author":"Wu","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.amjoto.2025.104765_bb0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2222.1998.00237.x","article-title":"Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?","volume":"28","author":"White","year":"1998","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.amjoto.2025.104765_bb0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/all.14561","article-title":"Clinical characteristics of allergic rhinitis patients in 13 metropolitan cities of China","volume":"76","author":"Zheng","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.amjoto.2025.104765_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115903","article-title":"Effects of pollen concentration on allergic rhinitis in children: a retrospective study from Beijing, a Chinese megacity","volume":"229","author":"Zhao","year":"2023","journal-title":"Environ Res"},{"key":"10.1016\/j.amjoto.2025.104765_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.154882","article-title":"Pollen season trends as markers of climate change impact: Betula, Quercus and Poaceae","volume":"831","author":"Adams-Groom","year":"2022","journal-title":"Sci Total Environ"},{"issue":"3","key":"10.1016\/j.amjoto.2025.104765_bb0090","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/S2542-5196(19)30015-4","article-title":"Temperature-related changes in airborne allergenic pollen abundance and seasonality across the northern hemisphere: a retrospective data analysis","volume":"3","author":"Ziska","year":"2019","journal-title":"Lancet Planet Health"},{"issue":"2","key":"10.1016\/j.amjoto.2025.104765_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjoto.2025.104765_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2017.11.051","article-title":"Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma","volume":"142","author":"Weinstein","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.amjoto.2025.104765_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110721","article-title":"Stapokibart (CM310) targets IL-4R\u03b1 for the treatment of type 2 inflammation","volume":"27","author":"Liu","year":"2024","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.amjoto.2025.104765_bb0110","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2025.12515","article-title":"Stapokibart for severe uncontrolled chronic rhinosinusitis with nasal polyps: The CROWNS-2 Randomized Clinical Trial","volume":"334","author":"Shen","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amjoto.2025.104765_bb0115","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaad.2024.07.1447","article-title":"Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial","volume":"91","author":"Zhao","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.amjoto.2025.104765_bb0120","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/all.16368","article-title":"Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial","volume":"80","author":"Zhao","year":"2025","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.amjoto.2025.104765_bb0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40265-025-02151-7","article-title":"Stapokibart: first approval","volume":"85","author":"Shirley","year":"2025","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.amjoto.2025.104765_bb0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/CM9.0000000000002747","article-title":"Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 2b trial","volume":"137","author":"Zhao","year":"2024","journal-title":"Chin Med J"},{"issue":"7","key":"10.1016\/j.amjoto.2025.104765_bb0135","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s12325-024-02887-w","article-title":"Pharmacokinetics, pharmacodynamics, safety, and tolerability of stapokibart in healthy volunteers and adult subjects with atopic dermatitis","volume":"41","author":"Zhang","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.amjoto.2025.104765_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102076","article-title":"Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"61","author":"Zhang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.amjoto.2025.104765_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5415\/apallergy.0000000000000174","article-title":"Stapokibart (CM310) in patients with uncontrolled seasonal allergic rhinitis (PHECDA): rationale and design of a multicentre, randomized, double-blind, placebo-controlled study","volume":"15","author":"Wang","year":"2025","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.amjoto.2025.104765_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102467","article-title":"Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial","volume":"69","author":"Zhang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.amjoto.2025.104765_bb0155","article-title":"Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial","volume":"4","author":"Zhang","year":"2025","journal-title":"Nat Med Published online April"},{"issue":"10372","key":"10.1016\/j.amjoto.2025.104765_bb0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(22)02037-2","article-title":"An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study [published correction appears in Lancet. 2023 Jan 21;401(10372):194. doi: 10.1016\/S0140-6736(22)02581-8.]","volume":"401","author":"Guttman-Yassky","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.amjoto.2025.104765_bb0165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bjd\/ljad240","article-title":"Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial","volume":"189","author":"Weidinger","year":"2023","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.amjoto.2025.104765_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(21)00338-1","volume":"7","author":"Rubin","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjoto.2025.104765_bb0175","series-title":"Instructions for use of stapokibart injection [in Chinese]","author":"KeyMed Biosciences","year":"2024"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070925001681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070925001681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:38:51Z","timestamp":1781325531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070925001681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0196070925001681"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2025.104765","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stapokibart (CM310): A review in seasonal allergic rhinitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2025.104765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104765"}}